Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Universal Technical Institute, Inc.
NEW YORK, Nov. 30, 2012 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of Universal Technical Institute, Inc. ("UTI" or the "Company") (NYSE: UTI -News), concerning potential violations of federal securities laws.
On November 28, 2012, Shares of UTI fell $3.44 or 28% to close at $8.80 after disclosing in its 10K that in September it received a Civil Investigative Demand from the Attorney General of Massachusetts relating to pending investigation regarding of false claims allegations related to student loans, guarantees, grants. The investigation relates specifically to allegations that the Company caused false claims to be submitted to the Commonwealth relating to student loans, guarantees and grants provided to students at the Company's Norwood, Massachusetts campus. According to the Company's 10K, The Civil Investigative Demand required UTI to produce documents and provide written testimony regarding a broad range of the Company's business from September 2006 to the present. Then in October 2012, UTI said that it would not be able to provide the documentation ACCSC requested related to the preliminary investigation by the U.S. Department of Justice.
If you are aware of any facts relating to this investigation, or purchased shares of UTI, you can assist this investigation by contacting either Peretz Bronstein or Eitan Kimelman of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration.
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Eitan Kimelman , 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
More by this Source
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc.
May 22, 2013, 16:05 ET
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of iGATE Corporation
May 22, 2013, 08:30 ET
Bronstein, Gewirtz & Grossman, LLC Notifies Investors with Losses on Their Investment in Accretive Health, Inc. of Class Action Lawsuit and the Deadline to Seek a Lead Plaintiff Position
May 21, 2013, 16:05 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.